178 related articles for article (PubMed ID: 32037535)
41. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities.
Schmitt M; Depuydt C; Benoy I; Bogers J; Antoine J; Arbyn M; Pawlita M;
J Clin Microbiol; 2013 May; 51(5):1458-64. PubMed ID: 23447632
[TBL] [Abstract][Full Text] [Related]
42. Oncogenic human papillomavirus-infected immature metaplastic cells and cervical neoplasia.
van der Marel J; van Baars R; Alonso I; del Pino M; van de Sandt M; Lindeman J; ter Harmsel B; Boon M; Smedts F; Ordi J; Torné A; Jenkins D; Quint W
Am J Surg Pathol; 2014 Apr; 38(4):470-9. PubMed ID: 24503756
[TBL] [Abstract][Full Text] [Related]
43. High-Risk Human Papillomavirus Testing, Genotyping, and Histopathologic Follow-up in Women With Abnormal Glandular Cells on Papanicolaou Tests.
Zuo T; Levi AW; Lin Q; Abi-Raad R; Adeniran AJ; Cai G
Am J Clin Pathol; 2021 Sep; 156(4):569-576. PubMed ID: 33728437
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
[TBL] [Abstract][Full Text] [Related]
45. Distribution of high-risk human papillomavirus genotypes among HIV-negative women with and without cervical intraepithelial neoplasia in South Africa.
McDonald AC; Denny L; Wang C; Tsai WY; Wright TC; Kuhn L
PLoS One; 2012; 7(9):e44332. PubMed ID: 22970201
[TBL] [Abstract][Full Text] [Related]
46. Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities.
Gage JC; Schiffman M; Solomon D; Wheeler CM; Gravitt PE; Castle PE; Wentzensen N
Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1095-101. PubMed ID: 23603204
[TBL] [Abstract][Full Text] [Related]
47. [Risk stratification of type-specific human papillomavirus for cervical precancers: evidence from a cross-sectional study in Shenzhen].
Liu ZH; Lin W; Wang YY; Wu B; Yuan SX; Yao JL; Zhao XS; Chen B; Qiao YL; Zhao FH; Chen W; Hu SY
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):757-763. PubMed ID: 30392340
[No Abstract] [Full Text] [Related]
48. Screening for persistent high-risk HPV infections may be a valuable screening method for young women; A retrospective cohort study.
Ebisch RMF; Ketelaars PJW; van der Sanden WMH; Schmeink CE; Lenselink CH; Siebers AG; Massuger LFAG; Melchers WJG; Bekkers RLM
PLoS One; 2018; 13(10):e0206219. PubMed ID: 30356297
[TBL] [Abstract][Full Text] [Related]
49. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
50. Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China.
Lin CQ; Cui JF; Zhang X; Pan QJ; Chen W; Qiao YL
Acta Cytol; 2015; 59(5):405-11. PubMed ID: 26565687
[TBL] [Abstract][Full Text] [Related]
51. High prevalence of HPV59 in cytologically abnormal cervical samples.
Ye F; Chan N; Feng T; Wu J; Jiang S; Sperling R; Zhang DY
Exp Mol Pathol; 2015 Dec; 99(3):611-6. PubMed ID: 26450267
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of high-grade cervical intraepithelial neoplasia in women with persistent high-risk HPV genotypes and negative cytology.
Macdonald M; Crossley J; Ellis K; Dudding N; Lyon R; Smith JHF; Tidy JA; Palmer JE
Cytopathology; 2018 Apr; 29(2):133-142. PubMed ID: 29350424
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
[TBL] [Abstract][Full Text] [Related]
54. HPV testing in cervical screening.
Brink AA; Snijders PJ; Meijer CJ; Berkhof J; Verheijen RH
Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):253-66. PubMed ID: 16359926
[TBL] [Abstract][Full Text] [Related]
55. The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples.
Ebisch RM; de Kuyper-de Ridder GM; Bosgraaf RP; Massuger LF; IntHout J; Verhoef VM; Heideman DA; Snijders PJ; Meijer CJ; van Kemenade FJ; Bulten J; Siebers AG; Bekkers RL; Melchers WJ
Int J Cancer; 2016 Aug; 139(3):691-9. PubMed ID: 26991464
[TBL] [Abstract][Full Text] [Related]
56. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
Leeman A; Del Pino M; Marimon L; Torné A; Ordi J; Ter Harmsel B; Meijer CJLM; Jenkins D; Van Kemenade FJ; Quint WGV
Int J Cancer; 2019 Jan; 144(1):160-168. PubMed ID: 30098013
[TBL] [Abstract][Full Text] [Related]
57. How best to interpret mixed human papillomavirus genotypes in high-grade cervical intraepithelial neoplasia lesions.
Callegari ET; Tabrizi SN; Pyman J; Saville M; Cornall AM; Brotherton JM; Garland SM
Vaccine; 2014 Jul; 32(32):4082-8. PubMed ID: 24857693
[TBL] [Abstract][Full Text] [Related]
58. The Clinical Utility of Extended High-Risk HPV Genotyping in Women With ASC-US Cytology.
Jiang W; Austin RM; Zhang H; He Y; Xu L; Wu X; Kuang W; Tong L; Li L; Zhao C
Am J Clin Pathol; 2022 Oct; 158(4):472-479. PubMed ID: 35849091
[TBL] [Abstract][Full Text] [Related]
59. Machine Learning Interpretation of Extended Human Papillomavirus Genotyping by Onclarity in an Asian Cervical Cancer Screening Population.
Wong OGW; Ng IFY; Tsun OKL; Pang HH; Ip PPC; Cheung ANY
J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31511337
[TBL] [Abstract][Full Text] [Related]
60. Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.
Perez S; Iñarrea A; Pérez-Tanoira R; Gil M; López-Díez E; Valenzuela O; Porto M; Alberte-Lista L; Peteiro-Cancelo MA; Treinta A; Carballo R; Reboredo MC; Alvarez-Argüelles ME; Purriños MJ
Virol J; 2017 Nov; 14(1):214. PubMed ID: 29110680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]